Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.67
+0.09 (1.61%)
At close: Jan 7, 2026, 4:00 PM EST
5.75
+0.08 (1.48%)
After-hours: Jan 7, 2026, 7:18 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $311.27 million as of January 7, 2026. Its market cap has increased by 12.23% in one year.
Market Cap
311.27M
Enterprise Value
229.87M
1-Year Change
12.23%
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $311.27M, an increase of 39.97%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 306.33M | -1.24% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.51B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |